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lytic subunit of the mitochondrial DNA polymerase gamma gene (POLG). Reprogramming factors Oct3/4, Sox2,
Klf4, and cMyc were delivered using a non integrative methodology that involves the use of Sendai virus.
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The generation of the human iPSC line, PG64SV.2, was carried out
using non-integrative Sendai viruses containing the reprogramming
factors, Oct3/4, Sox2, cMyc, Klf4 (Takahashi et al., 2007). For this pur-
pose, ﬁbroblasts from a patientwith a defect of intergenomic communi-
cation (Hirano et al., 2001)were provided by EuroBiobank. The patient's
ﬁbroblasts carried a homozygous mutation in the gene encoding the
catalytic subunit of the mitochondrial DNA polymerase gamma (POLG)
(c.2243GNC; p.Trp748Ser). The presence of this mutation in the iPSC
line was conﬁrmed by Sanger sequencing (Fig. 1A). PG64SV.2 iPSC col-
onies displayed a typical ES-like colonymorphology and growth behav-
ior (Fig. 1B) and they stained positive for alkaline phosphatase activity
(Fig. 1C). We conﬁrmed the clearance of the vectors and the exogenous
reprogramming factor genes by RT-PCR after eight culture passages
(Fig. 1D). The endogenous expression of the pluripotency associated
transcription factors Oct4, Sox2, Klf4, Nanog, Crypto and Rex1 was
also evaluated by RT-PCR (Fig. 1E). Immunoﬂuorescence analysis re-
vealed expression of transcription factors OCT4, NANOG, SOX2 and sur-
face markers SSEA3, SSEA4, TRA1-60 and TRA1-81 characteristics of
pluripotent ES cells (Fig. 1F). Promoters of the pluripotency associated
genes, OCT4 and NANOG, heavily methylated in the original ﬁbroblasts
were almost demethylated in the PG64SV.2 line suggesting an epigenet-
ic reprogramming to pluripotency (Fig. 1G). The iPSC line has been
adapted to feeder-free culture conditions and displays a normal karyo-
type (46, XX) after more than twenty culture passages (Fig. 1H). We
also conﬁrmed by DNA ﬁngerprinting analysis that the line PG64SV.2the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Molecular and functional characterization of the PG64SV.2 iPSC line. 1A. Electropherograms showing the c.2243G N Cmutation in the patient's ﬁbroblasts and in the PG64SV.2 line.
1B. Typical ES-like colony morphology of the PG64SV.2 iPSC line. 1C. Positive phosphatase alkaline staining. 1D. Conﬁrmation by RT-PCR of the exogenous reprogramming factors and
sendai virus vector silencing. 1E. QPCR showing the expression of the pluripotency associated markers NANOG, OCT4, SOX2, KLF4, CRIPTO and REX1. 1F. Immunoﬂuorescence analysis
showing expression of typical pluripotent ES cell markers such as the transcription factors Oct4, Nanog, Sox2 and the surface markers SSEA3, SSEA4, Tra1-60 and Tra1-81; scale bars:
300 μm. 1G. Bisulﬁte pyrosequencing of the OCT4 and NANOG promoters. The promoters of the transcription factors, OCT4 and NANOG were almost demethylated in the generated
iPSC line. 1H. Karyotype analysis. PG64SV.2 has a normal karyotype (46, XX). 1I. DNA ﬁngerprinting analysis showing that PG64SV.2 comes from the patient's ﬁbroblasts. 1J. Embryoid
body based in vitro differentiation assays. PG64SV.2 differentiates into all three germ layers, demonstrated by positive AFP endoderm staining (l), positive Tuj1 ectoderm staining and
positive SMA mesoderm staining.
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of the generated iPSC line to differentiate into the three germ layers
(endoderm, mesoderm and ectoderm) was tested in vitro using an em-
bryoid body based assay (Fig. 1J).3. Materials and methods
3.1. Non-integrative reprogramming of mutant POLG ﬁbroblasts into iPSC
All the experimental protocols included in the present study were
approved by the Institutional Ethical Committee of the Autonoma Uni-
versity of Madrid according to Spanish and European Union legislation.
Human ﬁbroblasts from a patient presenting with a defect of
intergenomic communication caused by a homozygous mutation in
the POLG gene (c.2243GNC; p.Trp748Ser) were obtained from
EuroBiobank (http://www.eurobiobank.org/en/services/services.htm).
These ﬁbroblasts were reprogrammed using the CytoTune-iPS 2.0
Sendai reprogramming kit following the instructions of themanufactur-
er. After eight passages of the iPSC line, silencing of the exogenous
reprogramming factors genes and sendai virus genome was conﬁrmed
by RT-PCR following the manufacturer's instructions. PG64SV.2 was
maintained and expanded both on feeder layers and on feeder-free
layers. In the ﬁrst case, irradiated human ﬁbroblast feeders with ES me-
dium containing: Knockout DMEM (Life technologies), Knockout serum
replacement 20%, (Life technologies), MEM non-essential amino acids
solution 1X (Life technologies), GlutaMAX 1X (Life technologies), β-
mercaptoethanol (100 μM), penicillin/streptomycin 1X (Life technolo-
gies) and bFGF (4 ng/ml) (Miltenyi Biotec) were used. Subsequently,
PG64SV.2 was adapted and cultured in feeder-free conditions on
matrigel (354,277, Corning) with mTeSR1 medium (StemCell) follow-
ing the recommendations of the manufacturer. For the propagation of
the line, both enzymatic (dispase, collagenase IV and accumax) andme-
chanical procedures have been used.3.2. Phosphatase alkaline analysis
The iPSC line PG64SV.2 was seeded on a feeder layer plate. After six
days direct phosphatase alkaline activity was determined using the
phosphatase alkaline blue membrane substrate solution kit (Sigma,
AB0300) following the instructions of the manufacturer.3.3. Mutation analysis
Total DNA from the patient's ﬁbroblasts and iPSCs was extracted
using a standard phenol-chloroform protocol. Subsequently, ampliﬁca-
tion by PCR of the of POLG gene region containing the c.2243GNCmuta-
tion (exon 13) was carried out using the following primers: POLG-13F:
5′- ATGGCCCTTGCTGAATGCAG-3′ and POLG-13R: 5′-TGGGCCTTGAGC
AGAATGAG-3′. Following PCR ampliﬁcation, direct sequencing of
amplicons was performed on both strands in an ABI 3730 sequencer
(Applied Biosystems; Foster City, CA) using a dye terminator cycle se-
quencing kit (Applera, Rockville, MD).3.4. QPCR analyses
Total mRNAwas isolated using TRIZOL and 1 μg was used to synthe-
size cDNA using theQuantitect reverse transcription cDNA synthesis kit.
One microliter of the reaction was used to quantify by qPCR the expres-
sion of the endogenous pluripotency associated genes (OCT4, SOX2,
KLF4, NANOG, CRIPTO and REX1). Primer sequences were described by
Aasen et al., 2008. All the expression values were normalized to the
GAPDH housekeeping gene. Plots are representative of at least three in-
dependent experiments.3.5. Bisulﬁte pyrosequencing
Bisulﬁte modiﬁcation of genomic DNA was performed with the EZ
DNAMethylation-Gold kit (ZymoResearch) following themanufacturer's
instructions. The set of primers for PCR ampliﬁcation and sequencing of
NANOG and OCT4were designed using the software PyroMark Assay De-
sign (version 2.0.01.15; Qiagen): Forward-NANOG (5′-TAT TGG GAT TAT
AGG GGT GGG TTA-3′), Reverse-NANOG (5′-[Btn]- CCC AAC AAC AAA
TAC TTC TAA ATT CAC-3′), and sequencing primer S-NANOG (5′-ATA
GGG GTG GGT TAT-3′); Forward-OCT4_prox (5′- GGG GTT AGA GGT
TAA GGT TAG TG-3′), Reverse-OCT4_prox (5′-[Btn]- ACC CCC CTA ACC
CAT CAC-3′), and sequencing primer S-OCT4_prox (5′-GGG GTT GAG
TAG TTT-3′); Forward-OCT4_dist (5′- TTT TTG TGG GGG ATT TGT ATT
GA-3′), Reverse-OCT4_dist (5′-[Btn]- AAA CTA CTC AAC CCC TCT CT-3′),
and sequencing primer S-OCT4_dist (5′-ATT TGT ATT GAG GTT TTG
GA-3′). PCR was performed with primers biotinylated to convert the
PCR product to single-stranded DNA templates, using the Vacuum
Prep Tool. After PCR ampliﬁcation, pyrosequencing reactions andmeth-
ylation quantiﬁcation were performed using PyroMark Q24 reagents,
equipment and software (version 2.0.6; Qiagen), according to the
manufacturer's instructions.
3.6. Karyotype analysis
Karyotype analyses of the iPSC line were carried out using cells with
more than twenty culture passages. These cells were processed using
standard cytogenetic techniques. Brieﬂy, cells were treated with
10 μg/ml of Colcemid (Gibco) for 90 min at 37 °C, trypsinized, treated
with 0.075 M hypotonic KCl solution, and ﬁxed with Carnoy's ﬁxative.
Cells were then dropped on a microscope glass slide and dried.
Metaphase cells were G banded usingWright staining. At least 20meta-
phases were karyotyped.
3.7. Immunoﬂuorescence analysis
Cells were grown on 0.1% gelatin-coated P35 culture plates (81,156,
Ibidi) andﬁxedwith 4% paraformaldehyde. The following antibodies for
the stainingwere used: TRA-1-60 (Millipore;MAB4360; 1:150); TRA-1-
81 (Millipore; MAB4381; 1:150); SOX2, (Thermo Scientiﬁc; PA116968;
1:100); NANOG (R&D Systems; AF1997; 1:25); SSEA-4 (Millipore;
MAB4304; 1:10); SSEA-3 (Millipore; MAB4303; 1:10); OCT4 (Santa
Cruz Biotechnology; Sc-5279; 1:100); neuron-speciﬁc class III beta-
tubulin (Tuj1) (Sigma, T8660, 1:300), α-fetoprotein (AFP) (Sigma,
WH0000174M1, 1:300), smooth muscle alpha actin (SMA) (Sigma,
A2547, 1:400). Secondary antibodies used were all from the Alexa
Fluor Series from Jackson Immunoresearch (all 1:500). Images were
taken using a Zeiss confocal microscope.
3.8. In vitro differentiation assay
The in vitro pluripotency capacity of the iPSC line was tested by
spontaneous embryoid body differentiation. For this purpose, iPSCs
from a P100 plate with 80% of conﬂuencywere dissociated into a single
cell suspension with accumax (SCR006,Millipore) and resuspended in
12 ml of mTeSR1 medium (Stemcell). Embryoid body formation was
induced by seeding 120 μl of the iPSC suspension in each well of 96-
well v-bottom low attachment plates and centrifuging the plates at
800 g for 10 min to aggregate the cells. After 2–3 days the embryoid
bodies were transferred to an untreated P60 culture plate for 2–
4 days. Subsequently, the embryoid bodies were transferred to 0.1%
gelatin-coated P35 culture plates (81,156, Ibidi) and cultured in differ-
entiation medium (DMEM F12 supplemented with 20% fetal bovine
serum, 2 mM glutamine, 0.1 mM β-mercaptoethanol, 1X non essential
amino acids and 1X penicillin–streptomycin, all from Invitrogen) for
2–3 weeks to allow spontaneous endoderm formation. For mesoderm
differentiation, iPSCs were maintained for 2–3 weeks in differentiation
123F. Zurita et al. / Stem Cell Research 16 (2016) 120–123medium supplemented with 100 μM ascorbic acid (A4403, Sigma-
Aldrich). For ectoderm differentiation, embryoid bodies were trans-
ferred to matrigel coated P35 culture plates and cultured in a special
differentiation medium containing (50% DMEM F12, 50% neurobasal
medium, 1X GlutaMAX, 1X penicillin–streptomycin, non-essential
amino acids, 0.1 mM 2-mercaptoethanol, 1X N2 supplement and 1X
B27 supplement, all from Invitrogen). In all the cases, the medium was
changed every other day.
3.9. DNA ﬁngerprinting analysis
For DNA ﬁngerprinting analysis, highly polymorphic regions con-
taining short tandem repeated sequences of DNA have been evaluated.
For this purpose, the following markers (D13S317, D7S820, VWA,
D8S1179, D21S11, D19S433, D2S1338 and amelogenin for sex determi-
nation) have been ampliﬁed by PCR and analyzed by ABI PRISM 3100
Genetic analyzer and Peak Scanner v3.5 (Applied Biosystems). Primer
sequences and PCR conditions are available upon request.
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